General Information of the Compound
| Compound ID |
CP0448312
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3-pyridin-2-ylisoquinolin-1-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
BDBM50067096
CHEMBL71053
GTPL476
N-(3-(pyridin-2-yl)isoquinolin-1-yl)benzamide
N-(3-Pyridin-2-yl-isoquinolin-1-yl)-benzamide
N-(3-Pyridin-2-yl-isoquinolin-1-yl)-benzamide(VUF8507)
N-(3-pyridin-2-ylisoquinolin-1-yl)benzamide
N-[3-(2-pyridinyl)-1-isoquinolinyl]benzamide
SCHEMBL1003046
VUF 8507
VUF-8507
VUF8507
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H15N3O
|
||||||||||||||||||
| Molecular Weight |
325.371
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1nc(cc2ccccc12)-c1ccccn1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H15N3O/c25-21(15-8-2-1-3-9-15)24-20-17-11-5-4-10-16(17)14-19(23-20)18-12-6-7-13-22-18/h1-14H,(H,23,24,25)
Show/Hide
|
||||||||||||||||||
| InChIKey |
FWRPUFITEHOETQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound